Statement on Global Settlement

“Dana-Farber Cancer Institute, Inc., Bristol Myers Squibb Co., and Ono Pharmaceutical Co., Ltd. have entered into a global agreement to settle all disputes relating to the Honjo-Freeman Patents. Under the agreement, Bristol Myers Squibb and Ono will make a lump-sum payment to Dana-Farber, with the possibility of additional payments in the future.

All other terms of the agreement are confidential. This resolution paves the way for our continued focus on pioneering discoveries that have enabled cancer immunotherapies and advances our shared goal to provide extraordinary care for our patients.”